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In this context, it has always been welcomed to come upon
a ‘pristine’ renal allograft biopsy that not only poses no diag-
nostic difﬁculty but also appears to predict a long and healthy
allograft life. The study of Naesens et al. provides evidence to
the contrary.
We have previously observed that routine immunohisto-
chemical evaluation highlights inﬂammatory changes in renal
allografts that may be below the current diagnostic thresholds
for allograft rejection.3 More speciﬁcally, CD3 and CD68
stains can demonstrate a subtle increase in T-lymphocytes
and macrophages even in well-functioning allografts that are
unsuspected on routine stains (Figure 1). This may correlate
with the ﬁndings of Naesens et al. at the molecular level.
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The Authors Reply: We thank Drachenberg and Papadimi-
triou1 for sharing their immunohistochemical data in a
6-month protocol biopsy of a well-functioning renal allograft.
This information adds to the validity of our molecular study2
and illustrates that subtle inﬂammation below the standard
histological thresholds does exist in apparently normal kidneys
without inﬂammation on routine tissue stains.
Moreover, their case suggests that we possibly do not need
laborious molecular techniques to assess this subtle inﬂam-
mation, but that immunohistochemical stains for speciﬁc
targets (e.g., CD3 stains for T lymphocytes and CD68 stains
for macrophage inﬁltration) could serve the purpose as well.
Although combined molecular and immunohistochemical
studies are needed to evaluate the quantitative threshold of
positive immunohistochemistry, it is reassuring that the
‘transcriptomic alteration’ state, suggested by Fehr and
Cohen,3 could potentially be picked up by more standard
procedures such as immunohistochemistry. We therefore
consider that the term ‘subtle inﬂammation’ is more
appropriate to describe this stage of ongoing allograft
injury.
It is tempting to concatenate our ﬁnding—that subtle
inﬂammatory signatures in protocol biopsies associate with
progressive chronic histological damage in the ﬁrst years after
transplantation2—with previous data by Papadimitriou et al.4
on the association between subtle glomerular inﬂammation
and long-term graft survival, and hypothesize that our
molecular data are the reﬂection of a subtle but deleterious





Figure 1 |Histological evaluation of renal allograft biopsy.
(a) Randomly selected field in a 6-month-protocol renal allograft
biopsy sample from a 66-year-old man with a serum creatinine
level of 1.16mg/dl. Inflammation is not significant on periodic
acid Schiff stain. C4d stain was negative (not shown) and a
concurrent serological study was negative for donor-specific
antibodies. (b) CD3 highlights several T-lymphocytes in the
interstitium and within the tubular basement membranes
(arrows). (c) CD68 stain demonstrates occasional interstitial
macrophages (arrow).
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However, in our study, it is not determined whether the
association between molecular signatures or subtle inﬂam-
mation in early protocol biopsies and progressive chronic
injury is causal or merely the consequence of yet unidentiﬁed
or previous injury processes, and the reﬂection of tissue
healing.5
We therefore agree with Fehr and Cohen3 that more
research is necessary to elucidate the etiology and long-term
impact of subtle inﬂammation within renal allografts. Only
when the etiology and impact are deciphered in more detail,
can we start thinking about how to respond therapeutically to
subtle inﬂammation in renal allograft biopsies of individual
patients and alter the inexorable cascade of chronic allograft
injury.
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